Patents diary June 2020: UK Supreme Court holds Regeneron's transgenic mice patents invalid
Territorial licensing: "start at the end before you begin"
by Colin McCall and Justyna Ostrowska
Impact of COVID-19 on venture-backed biotech companies – Part 2: Investment and cash flow
by Adrian Toutoungi and Josef Fuss
Impact of COVID-19 on venture-backed biotech companies – Part 1: Operational issues
by Adrian Toutoungi and Josef Fuss
NHS can procure drugs for use outside of their approved indications if it's cheaper, court says
Everything biologic and biosimilar in-house counsel need to know about COVID-19
by multiple authors